Company Data

Neovasc Inc.

Fundamental Analysis:

Neovasc Inc.

Neovasc Inc.
Fundamental Analysis:
Ticker
NVCN:CA
Current Price
$10.98
Market Cap
$30.2M
Price Target
Refer to Report
52wk Range
$6 - $25
Advanced Market Data

Overview

Neovasc Inc is a specialty medical device company. The company develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products include the Tiara for the transcatheter treatment of mitral valve disease and the Neovasc Reducer for the treatment of refractory angina. Neovasc is developing the Tiara for the treatment of mitral valve disease. Neovasc operates its business in one segment.

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy
© 2018-2022 Noble Financial Group, Inc. All Rights Reserved. Channelchek is provided at no cost to be used for information purposes only and not as investment advisement.